CAR-T is a type of treatment where some of your own immune cells are collected, carefully modified in a lab to better recognise cancer cells, and then returned to your body to fight the disease.
As new clinical trials or access programs open, your oncologist or haematologist will know if you may be able to participate.
Immuna’s mission is to dramatically reduce the cost of advanced therapies compared to currently marketed products. Actual costs depend on country, programme type (clinical trial, early access or standard-of-care), and agreements with payers or public health systems.
Nothing on this website is medical advice. Always discuss treatment options with your doctor and care team.
Whether you are a clinician, hospital administrator, policymaker, investor, or patient advocate, Immuna welcomes collaboration to bring advanced therapies to the communities that need them most.